CDW CORP (CDW): what the price requires

Generated: 2026-07-14 · Exported: 2026-07-16 · Source: https://boothcheck.com/report/CDW

Headline

Field	Value
Ticker	CDW
Company	CDW CORP
Current price	$144.52/sh
Composition	Hardware 72% / Software 19% / Services 9% / Other 1%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

Field	Value
Inversion basis	whole-company
Operating margin needed	3.3%
Operating margin today	7.1%
Margin compression implied	-3.8pp
Implied growth	2.7%
Multiple paid	15x operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

Solve inputs: computed at a 8.5% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~6.2pp.

How unusual the bet is: within-range (limited comparison data)

Reference	Value
vs own history	-0.84σ
implied end-window share	0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

Family	Median price/FV	Models	Reads
Asset	1.61x	5	expensive
Earnings	1.63x	5	expensive
Relative	0.84x	5	justifies
Growth	0.76x	3	justifies

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 7.9%); the inversion above states its own rate.

Per-Model Detail (n=18)

Model	Family	FV	Price/FV	Applicable	Methodology
DCF Perpetual Growth	Growth	$233.58	0.62x	yes	FCF base $1.1B, growth 7% (input: historical growth), terminal g 4.0%, WACC 7.9%, 6yr projection
DCF Exit Multiple	Growth	$191.28	0.76x	yes	Exit EV/EBITDA: 10.2x / 12.2x / 14.2x (bear / base = today's held flat / bull), 6yr
Relative Valuation	Relative	$175.54	0.82x	yes	P/E 20x (static sector reference · 2026-04), scenarios: 16.7x / 20.0x / 23.3x (bear / base = reference held flat / bull), EV/EBITDA 14x
Simple DDM	Growth	—	—	no	—
Two-Stage DDM	Growth	—	—	no	—
Simple Excess Return	Asset	$89.92	1.61x	yes	BV/sh $19.73, ROE (TTM) 42.1%, ke 9.3%
Two-Stage Excess Return	Asset	$217.40	0.66x	yes	5yr excess ROE then converge to ke=9.3%
Discounted Future Market Cap	Growth	$137.66	1.05x	yes	Rev $22.9B, growth 7% (input: historical growth; tapered), Terminal P/S: 0.7x / 0.8x / 1.0x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair Value	Relative	$98.52	1.47x	yes	EPS $8.21, growth 2% (input: historical EPS growth), PEG=7.48 (Overvalued)
Margin Trajectory	Growth	—	—	no	—
Earnings Power Value	Earnings	$89.92	1.61x	yes	Normalized EBIT (5y avg op income, one-time charges added back) $1.64B × (1−26%) / WACC 7.9% → EPV (no growth)
Residual Income	Asset	$143.17	1.01x	yes	BV $19.73 + 5yr PV of (ROE (TTM) 42.1% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham Number	Asset	$60.38	2.39x	yes	√(22.5 × EPS $8.21 × BVPS $19.73) — Graham's conservative floor
EV/EBITDA Relative	Relative	$172.27	0.84x	yes	EBITDA $1.97B × sector EV/EBITDA 14.0x
FCF Yield	Earnings	$49.59	2.91x	yes	FCF $1076.2M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF Yield	Earnings	$42.48	3.40x	yes	SBC-adj FCF $0.99B (FCF $1.08B − SBC $0.09B) capitalized at Kₑ
Ben Graham Formula	Earnings	$90.46	1.60x	yes	EPS $8.21 × (8.5 + 2×2.3%) × (4.4 / 5.3%)
ROIC-Justified P/B	Asset	$8.88	16.27x	yes	BV $19.73 × (ROIC 3.6% / WACC 7.9%)
P/Sales Sector	Relative	$265.31	0.54x	yes	Revenue $22.90B × sector P/S 1.5x
PEG Fair Value	Relative	$41.05	3.52x	yes	EPS $8.21 × (PEG 1.5 × growth 2.3% (input: historical EPS growth)) → PE 3.5x
Earnings Yield	Earnings	$88.76	1.63x	yes	EPS $8.21 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations Multiple	Relative	—	—	no	—
Clinical Phase NPV	Growth	—	—	no	—
Merton	Asset	—	—	no	—
V5 Mechanical	—	—	—	no	—

Solvency

Field	Value
Net debt	$5.1b
Net debt / NOPAT (after-tax)	4.30x
Net debt / operating income (pre-tax)	3.17x
Share count CAGR (buyback)	-1.3%
Burning cash	no

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

At $128.40 (as of June 27, 2026) the price pays about 14x company-wide operating income, which inverts to roughly 0.1% operating-profit growth per year for five years. That is close to a no-growth bar for a business that grew net sales 9% last quarter, so the market is asking very little of CDW from here.

The price sits below most of the growth and peer-multiple methods (perpetual-growth DCF near $243, relative valuation near $176, EV/EBITDA relative near $172) and above the cash-flow and asset floors (FCF-yield methods near $42 to $50). The growth and relative-multiple lenses value the business above the quote; the asset and earnings lenses defend values about a third below it.

The debate is margin, not demand. Q1 2026 beat on revenue and earnings, but gross margin fell on product mix toward lower-margin hardware, and the stock sold off hard on the print. The business is a high-volume, low-margin distributor of other people's technology, and the swing factor is whether the mix and the AI-hardware cycle help or hurt the spread.

Bull Case

Start with where the price sits against the methods, because that is unusually favorable here. Group the valuation families and the pattern is the inverse of an expensive stock: the forward-growth DCF lands near $243, the relative-valuation and EV/EBITDA-relative methods near $172 to $176, the two-stage excess-return method near $217, and the discounted-future-market-cap method near $122, all at or above the $128.40 quote. Only the cash-flow-yield and Graham floors sit below the price. When the growth and peer-multiple frames cluster above the quote and only the most conservative floors sit under it, the market is paying a below-average multiple for an established business, which is exactly what the inversion confirms.

That inversion is the core of the bull case. At about 14x operating income the price implies roughly 0.1% annual operating-profit growth held for five years. CDW does not need to grow to justify the price; it needs to not shrink. Against that bar, Q1 2026 net sales rose 9% year over year to $5.7 billion, gross profit grew 6% to a first-quarter record of $1.2 billion, and EPS of $2.28 beat the estimate. The company guides to outperforming a low-single-digit U.S. IT market by 200 to 300 basis points and to low-to-mid-single-digit gross-profit growth for the full year.

The business model is the third leg. CDW is an asset-light intermediary between thousands of technology vendors and a fragmented base of corporate, government, education, and healthcare buyers. Its 10-K notes that it resells cloud-based solutions, software, and hardware and earns vendor programs such as 'purchase or sales rebates and cooperative advertising reimbursements' (FY2025 10-K, accession 0001402057-26-000011). The value it adds is helping customers navigate a landscape the same filing describes as evolving toward cloud-based and other as-a-service solutions, hyper-converged infrastructure, embedded software solutions, and solutions that incorporate AI. Complexity is CDW's product. As enterprises stitch together AI infrastructure from many vendors, the advisory-and-fulfillment role gets more valuable, not less, and CDW converts that into steady cash with modest capital needs.

Bear Case

The competitive disruption case names specific threats before it reaches a single multiple. CDW sits between vendors and buyers, and both ends can route around it. On one side are large peers like Insight Enterprises competing for the same solutions business; on the other are the hyperscalers and OEMs selling cloud capacity and hardware directly, plus the marketplace model that lets buyers transact without a reseller. CDW's own 10-K concedes the market is 'highly competitive' and that 'competitive sources of supply are available in substantially all of the product categories that we offer,' and warns the landscape will keep evolving toward as-a-service, hyper-converged, and AI-incorporating models that could affect its sales, profit margins, and earnings (FY2025 10-K, accession 0001402057-26-000011). A distributor whose suppliers can sell direct and whose customers can buy direct has structurally capped pricing power.

That shows up immediately in the margin line, which is where Q1 2026 actually cut against the bull. Revenue and earnings beat, but gross margin fell on a product mix that shifted toward lower-margin hardware, and the stock dropped roughly 20% on the print. The market read a record gross-profit dollar figure but a thinner spread, and concluded the AI-hardware demand driving the top line is the least profitable part of the mix. For a business with a 7.3% operating margin, small moves in spread matter enormously to the bottom line, and a hardware-led cycle is precisely the kind that pads revenue while squeezing profitability.

The third risk is the cyclicality the low-growth price is meant to compensate for. CDW resells discretionary technology spending, which customers can defer when budgets tighten. The company carries net debt of about $5.1 billion against trailing operating income near $1.67 billion, roughly 3x, so a demand air-pocket would hit a leveraged distributor. Guidance itself flags a front-loaded year driven by 'customer urgency,' which is a polite way of saying some Q1 demand was pulled forward. If enterprises are digesting recent technology investments, as the skeptical analyst read suggests, then the low-single-digit market growth CDW plans to beat could itself prove optimistic, and a no-growth price stops being a cushion when actual operating income declines.

Valuation

The X-ray reads like a value name rather than a growth one. The forward-growth methods sit above the price (perpetual-growth DCF near $243, exit-multiple DCF near $177, discounted-future-market-cap near $122), the peer-multiple methods cluster near $172 to $176 on the relative and EV/EBITDA approaches, and the excess-return frames range widely from about $90 to $217. The conservative floors are the only family below the quote: FCF-yield methods near $42 to $50, the Graham Number near $60, and PEG near $41. That is the signature of a multiple the market has marked down, not up.

Inverting the price makes the bet concrete. At about 14x company-wide operating income, CDW is priced for roughly 0.1% operating-profit growth per year over five years, solved at an 8.5% cost of capital with 4% terminal growth. The near-term pace the business already delivers is well within that bar; the question the inversion raises is not whether growth is fast enough but whether it stays positive at all. The multiple sits in the lower half of the peer range, and each percentage point of cost of capital moves the implied growth requirement by about 6 points, so the read is sensitive to rates but starts from a forgiving place. The real valuation argument is the one the bull and bear share: the price embeds almost no growth, so the outcome turns on margin direction. If the spread holds or recovers as the mix normalizes, a no-growth price on a low-single-digit-growth business is cheap. If the hardware-led mix permanently compresses margins, then operating income falls and the cheap multiple is cheap for a reason.

Catalysts

The Q1 2026 report was the live catalyst and it was a tale of two lines. Net sales rose 9% to $5.7 billion and EPS of $2.28 beat, gross profit hit a first-quarter record of $1.2 billion, yet the stock fell about 20% because gross margin compressed on a hardware-heavy product mix tied to AI infrastructure demand. The next several prints are a direct test of whether that margin pressure is a mix artifact that normalizes or a structural shift as the AI-hardware cycle runs. Management guided to low-to-mid-single-digit gross-profit growth for the full year, front-loaded to the first half on customer urgency, so the second-half comparison will show whether early demand was pulled forward.

The watch items are the IT-spending backdrop and the margin trajectory. CDW expects the U.S. IT addressable market to grow low single digits in 2026 and targets 200 to 300 basis points of outperformance, so the macro read on enterprise technology budgets is the demand variable that matters most. On the competitive side, any acceleration of hyperscaler direct sales, OEM direct channels, or as-a-service adoption would pressure the reseller spread the filing already flags. For a price that embeds almost no growth, the catalysts that move the stock are margin recovery, evidence the AI-hardware demand carries higher-margin services attach, and confirmation that the IT-spending cycle is not rolling over.

Sources: CDW Q1 2026 earnings transcript (Motley Fool), CDW Q1 2026 beats forecasts but stock slumps (Investing.com), CDW Q1 2026 deep dive on margin headwinds (StockStory), CDW FY2025 10-K.

Peer Cohorts (Per Segment, With Filing Citations)

Corporate / Small Business / Public (reported)

• NSIT (INSIGHT ENTERPRISES, INC.)
• (no filing in the citation store)
• SNX (TD SYNNEX CORPORATION)
• (no filing in the citation store)
• CNXN (PC CONNECTION, INC.)
• (no filing in the citation store)

Methodology Note

• Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
• Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
• Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
• Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.